Nkịta
Perrigo Company plc bu American Irish-registered manufacturer nke aha ahia gbasara ogwu, 70% ahia ha na ere so na U.S. healthcare system, Perrigo bu ezigbo headquarter no na Ireland nke tax purpose, nke na agbako 0.60%ahia ha erere. [1][2] N'afọ 2013, Perrigo rụzuru mgbanwe ụtụ isi ụlọ ọrụ US nke isii kachasị n'akụkọ ihe mere eme mgbe ọ degharịrị ọnọdụ ụtụ isi ya na Ireland iji zere ụtụ isi US.[3] Perrigo na-edebe isi ụlọ ọrụ ya na Grand Rapids, Michigan, n'ime Grand Rapids Innovation Park nke Mahadum Michigan State.[4]
Perrigo na-etinye aka n'inweta (maka repricing), imepụta, na ire ngwaahịa nlekọta ahụike ndị ahịa, ọgwụ ndị a na-edepụta, na ihe ndị na-arụ ọrụ na-emepụta ọgwụ (APIs), karịsịa na United States, site na isi ya na Ireland. N'abalị iri abụọ na otu n'ọnwa Disemba afọ 2018, ọnụahịa òkè Perrigo dara n'otu ụbọchị n'akụkọ ihe mere eme ya mgbe ndị Irish Revenue Commissioners wepụtara ụtụ isi megide Perrigo nke ruru ọkara nke uru ahịa ya.[5][6]
Akụkọ ihe mere eme
[dezie | dezie ebe o si]Ulooru L. Perrigo Ka achoputara na afo 1887 na Allegan, Michigan , ndi choputara ya bu Luther na Charles Perrigo na ere ahia.
N'afọ 1991, Perrigo nwere onyinye ihu ọha mbụ na NASDAQ.
Na Machị 2005 ụlọ ọrụ ahụ nwetara Agis Industries Limited (nke a na-ere dị ka AGIS na Tel Aviv Stock Exchange), ụlọ ọrụ na-emepụta ọgwụ na Israel na azụmahịa $ 850 nde. Ọ bụ Mori Arkin guzobere Agis na 1983, onye mepụtara obere azụmaahịa nna ya na-ebubata ọgwụ n'ime ụlọ ọrụ na-emepụta ọgwụ na mba dị iche iche. N'ihi nnweta ahụ, Arkin nwere 9% nke Perrigo, a họpụtakwara ya dị ka osote onyeisi oche nke ụlọ ọrụ ahụ.
N'ọnwa Julaị afọ 2013, Perrigo kwupụtara na ọ ga-eme mgbanwe ụtụ isi ụlọ ọrụ na Ireland iji zere ụtụ isi Ụlọ ọrụ US, site na nnweta ijeri $ 8.6 nke Ụlọ ọrụ Elan nke Irish.[7] Ka ọ na-erule n'ọnwa Nọvemba afọ 2018, Perrigo bụ nke isii kachasị na US. [8] [9] Ntụgharị ụtụ isi n'akụkọ ihe mere eme [3] Ihe karịrị 70% nke ahịa Perrigo, na ọbụna pasent ka ukwuu nke uru Perrigo, sitere na usoro ahụike US. [10][1]
N'ọnwa Eprel afọ 2015, Perrigo natara onyinye ịzụta na-arịọghị arịrịọ site n'aka Mylan nke ijeri $ 29, nke ndị njikwa na ndị nwere òkè mechara jụ. N'ọnwa Mee afọ 2016, ndị na-etinye ego na Perrigo gbara ụlọ ọrụ ahụ akwụkwọ maka nkwupụta ndị e mere n'oge Mylan bid, nke a sịrị na ha mere ka ndị nwere òkè tie vootu megide nkwekọrịta ahụ. [11][12][13] N'ime ọnwa ole na ole tupu ikpe a, onye isi oche na onye isi oche nke ụlọ ọrụ ahụ, Joseph Papa, onye a na-eto maka "ịgbachitere" mgbalị Mylan, hapụrụ iji were ọrụ onye isi oche ahụ na Valeant. [14][15] Mgbe Papa hapụrụ, John Hendrickson, onye bụ onye isi oche ụlọ ọrụ ahụ n'oge ahụ, were ọrụ ndị ọzọ nke onyeisi oche na onye isi oche. [16][17] Uwe Roehrhoff nọchiri Hendrickson na Jenụwarị, 2018. [18] Murray S. Kessler nọchiri Roehroff. Patrick Lockwood Taylor bụ onye isi ala na onye isi oche ugbu a.[19]
N'abalị iri abụọ n'ọnwa Disemba n'afọ 2018, Financial Times kọrọ na ndị Irish Revenue Commissioners natara ụtụ isi ijeri euro 1.64 (na-agụnyeghị ntaramahụhụ na ọmụrụ nwa) maka ụtụ isi a na-akwụghị ụgwọ (CGT) site na ire Tysabri na Biogen na 2013 site na Elan, nke mere ọnwa ole na ole tupu Perrigo enweta Elan.[20] Nkwupụta a bụ nke abụọ kachasị ukwuu nke ndị Revenue Commissioners nyere n'akụkọ ihe mere eme nke Ireland, mgbe Apple kwụsịrị ụgwọ ụtụ isi ijeri € 13 nke Irish.[1] Na 21 Disemba 2018, Irish Times kọrọ na Revenue kwuru na Perrigo ji CGT ụgwọ na ọnụego nke 33% dị ka "ahịa ahịa", agbanyeghị Perrigo kwuru na ire ya bụ akụkụ nke "ego ahịa" nke Elan, ma bụrụkwa nke dị ala 12.5% nke ụtụ isi ụlọ ọrụ Irish, nke Perrigo nwere ike belata na 0% site na iji ngwá ọrụ BEPS nke mba Ireland.[21]
Na June 2022, Perrigo kwagara isi ụlọ ọrụ ya site na Allegan gaa n'etiti obodo Grand Rapids, ihe dị ka kilomita 40 n'ebe ugwu, n'ime Grand Rapids Innovation Park nke Mahadum Michigan State.[4] Ụlọ ọrụ ahụ ka na-enwe ọfịs na mmepụta na ogige Allegan.
Na afo 2023, subsidiary, HRA Pharma natara nkwado n'aka FDA ere ogwu mgbochi over the counter ana akpo Opill.[22]
Akụkụ
[dezie | dezie ebe o si]- ↑ 1.0 1.1 (8 November 2018) Perrigo Co plc: Form 10-Q (29 September 2018). Securities and Exchange Commission. “Disaggregation of Revenue”
- ↑ Automation. "Perrigo Co. PLC stock rises Wednesday, still underperforms market", MarketWatch. Retrieved on 2021-07-22. (in EN-US)
- ↑ 3.0 3.1 "Tracking Tax Runaways", Bloomberg.com, Bloomberg News, 1 March 2017. “Bloomberg Special Reports: Corporate Tax Inversions”
- ↑ 4.0 4.1 McVicar (2022-06-30). Perrigo unveils new North American Corporate Headquarters on Grand Rapids' Medical Mile (en). mlive. Retrieved on 2022-10-27.
- ↑ Cantillion (21 December 2018). The terrible irony of Perrigo's tax planning. Irish Times.
- ↑ Charly Grant (21 December 2018). Perrigo Tax Shocker Couldn't Come at Worse Time. Wall Street Journal.
- ↑ UPDATE 4-U.S. drugmaker Perrigo to buy Ireland's Elan for $8.6 bln. Reuters (29 July 2013). “DUBLIN, July 29, 2013 (Reuters) - U.S. drugmaker Perrigo agreed to buy Elan for $8.6 billion in a deal that will hand it tax savings from being domiciled in Ireland and royalties from a blockbuster multiple sclerosis treatment.”
- ↑ Emily Stewart (22 July 2017). As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals. TheStreet.
- ↑ Danielle Douglas-Gabriel. "These are the companies abandoning the U.S. to dodge taxes", The Washington Post, 6 August 2014.
- ↑ Janet Novack (10 September 2014). The Tax Inversion Rush: One Handy Graphic. Forbes Magazine. “The U.S. company is in black, as is the share of the merged company its current shareholders will own; it must be less than 80% for the tax trick to work under the current law.”
- ↑ Bloomberg Industry Group. Bloomberg Industry. Archived from the original on 2024-05-15. Retrieved on 2024-05-16.
- ↑ Lawsuit filed against former Mylan acquisition target Perrigo - Pittsburgh Business Times.
- ↑ Perrigo Investor Slams Co. Over Mylan's Failed Takeover - Law360. www.law360.com.
- ↑ Lopez. "Now we know why Valeant's new CEO took the job, and it seems politicians are upset about it", Business Insider UK, 28 April 2016. Retrieved on 13 March 2018.
- ↑ Wright (9 January 2018). "Can Joseph Papa Save Valeant?". Life Science Leader. Retrieved on 13 March 2018.
- ↑ Helfand. "Floundering Perrigo's CEO Hendrickson to depart after rocky 13-month tenure", FiercePharma, 6 June 2017. Retrieved on 13 March 2018.
- ↑ "Valeant: Joseph Papa Joins Pharmaceutical Company As Chief Exec As Perrigo Names Hendrickson New CEO", International Business Times, 25 April 2016. Retrieved on 13 March 2018.
- ↑ "Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO", Reuters, 8 January 2018.
- ↑ Press Releases. Perrigo InvestorRoom.
- ↑ Authur Beesley (20 December 2018). Drugs group Perrigo hit with €1.64bn Irish back tax bill. Financial Times. “The tax assessment is Ireland’s largest since the European Commission directed Apple to pay €14.3bn in disputed back taxes to Dublin in a record-breaking ruling that the Irish authorities have taken to the European courts for an appeal.”
- ↑ Cliff Taylor (21 December 2018). What's the massive Perrigo tax bill all about?. Irish Times. “A twist is that Elan used accumulated losses to avoid paying any up-front tax bill at the time on the initial payment from Biogen.”
- ↑ FDA Approves First Nonprescription Daily Oral Contraceptive. Food and Drug Administration (13 July 2023).